speb/financial-data huggingface dataset:
CRCT balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 3815000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 51056000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 51056000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 170965000.00
CRCT cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -4798000.00
CRCT cash_flow (quarterly, 2025-03-31) — Deferred Tax: -4798000.00
CRCT cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 6105000.00
CRCT cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 6105000.00
CRCT income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 213839020.00
CRCT income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.11
CRCT income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 23914000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 32000.00
CRCT income_statement (quarterly, 2025-03-31) — EBIT: 32700000.00
CRCT income_statement (quarterly, 2025-03-31) — EBITDA: 38805000.00
CRCT cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 144000.00
CRCT cash_flow (quarterly, 2025-03-31) — End Cash Position: 252141000.00
CRCT cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -36417000.00
CRCT cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 56274000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 211000.00
CRCT income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 16665000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 73625000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Gross PPE: 50231000.00
CRCT income_statement (quarterly, 2025-03-31) — Gross Profit: 98348000.00
CRCT cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 279000.00
CRCT income_statement (quarterly, 2025-03-31) — Interest Expense: 79000.00
CRCT income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 79000.00
CRCT income_statement (quarterly, 2025-03-31) — Interest Income: 3357000.00
CRCT income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 3357000.00
CRCT cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 279000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Inventory: 114397000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Invested Capital: 490174000.00
CRCT cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -4892000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 10692000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 10692000.00
CRCT cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -12000000.00
CRCT cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -634000.00
CRCT income_statement (quarterly, 2025-03-31) — Net Income: 23914000.00
CRCT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 23914000.00
CRCT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 23914000.00
CRCT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 23914000.00
CRCT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 23914000.00
CRCT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 23914000.00
CRCT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 23914000.00
CRCT income_statement (quarterly, 2025-03-31) — Net Interest Income: 3278000.00
CRCT cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
CRCT income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 3278000.00
CRCT cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -2924000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Net PPE: 50231000.00
CRCT cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -4892000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 490174000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 44006000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 2717000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 2717000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 44006000.00
CRCT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 38805000.00
CRCT income_statement (quarterly, 2025-03-31) — Normalized Income: 23914000.00
CRCT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 61166000.00
CRCT cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -634000.00
CRCT income_statement (quarterly, 2025-03-31) — Operating Income: 29341000.00
CRCT income_statement (quarterly, 2025-03-31) — Operating Revenue: 162634000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 211775572.00
CRCT balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 17844000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 211000.00
CRCT income_statement (quarterly, 2025-03-31) — Other Gand A: 16665000.00
CRCT income_statement (quarterly, 2025-03-31) — Other Income Expense: 2000.00
CRCT cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 910000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 26183000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 7106000.00
CRCT income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 2000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Other Properties: 50231000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 104527000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Payables: 58301000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 116094000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CRCT income_statement (quarterly, 2025-03-31) — Pretax Income: 32621000.00
CRCT cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: -4868000.00
CRCT cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
CRCT cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -4892000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Receivables: 72325000.00
CRCT income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 64286000.00
CRCT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 6105000.00
CRCT cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -12000000.00
CRCT income_statement (quarterly, 2025-03-31) — Research And Development: 15657000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 25997000.00
CRCT cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
CRCT income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 36685000.00
CRCT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 53350000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Share Issued: 211775572.00
CRCT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 10450000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 490174000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 490174000.00
CRCT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CRCT income_statement (quarterly, 2025-03-31) — Tax Provision: 8707000.00
CRCT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.27
CRCT balance_sheet (quarterly, 2025-03-31) — Total Assets: 681654000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 490174000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Total Debt: 14507000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 490174000.00
CRCT income_statement (quarterly, 2025-03-31) — Total Expenses: 133293000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 191480000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 120420000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 20515000.00
CRCT income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 29341000.00
CRCT balance_sheet (quarterly, 2025-03-31) — Working Capital: 390269000.00
CRCT income_statement (quarterly, 2025-06-30) — +Operating Expense: 71434000.00
CRCT income_statement (quarterly, 2025-06-30) — +Total Revenue: 172112000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 71977000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 81990000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 308165000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -1600000.00
CRCT cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 309000.00
CRCT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 211865363.00
CRCT income_statement (quarterly, 2025-06-30) — Basic EPS: 0.12
CRCT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 252141000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 12481000.00
CRCT cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -5702000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 13393000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 212000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 298057000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 376941000.00
CRCT cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: 0.00
CRCT balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 75799000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Cash Financial: 222258000.00
CRCT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -11132000.00
CRCT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 20412000.00
CRCT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 36157000.00
CRCT cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 13440000.00
CRCT cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 2821000.00
CRCT cash_flow (quarterly, 2025-06-30) — Change In Inventory: -90000.00
CRCT cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -354000.00
CRCT cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -1123000.00
CRCT cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -142000.00
CRCT cash_flow (quarterly, 2025-06-30) — Change In Payable: 13440000.00
CRCT cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 16261000.00
CRCT cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 2100000.00
CRCT cash_flow (quarterly, 2025-06-30) — Change In Receivables: -9767000.00
CRCT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 6885000.00
CRCT cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -9767000.00
CRCT cash_flow (quarterly, 2025-06-30) — Changes In Cash: 45437000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Common Stock: 212000.00
CRCT cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: 0.00
CRCT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 308937000.00
CRCT cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -4741000.00
CRCT income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 70573000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 61657000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Current Assets: 599186000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 3609000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 3609000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 51047000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 51047000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 393104000.00
CRCT cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -5576000.00
CRCT cash_flow (quarterly, 2025-06-30) — Deferred Tax: -5576000.00
CRCT cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 5978000.00
CRCT cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 5978000.00
CRCT income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 214529726.00
CRCT income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.11
CRCT income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 24488000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 204814000.00
CRCT income_statement (quarterly, 2025-06-30) — EBIT: 33924000.00
CRCT income_statement (quarterly, 2025-06-30) — EBITDA: 39902000.00
CRCT cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 479000.00
CRCT cash_flow (quarterly, 2025-06-30) — End Cash Position: 298057000.00
CRCT cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -11132000.00
CRCT cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 30455000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 560000.00
CRCT income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 18795000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 83590000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Gross PPE: 50217000.00
CRCT income_statement (quarterly, 2025-06-30) — Gross Profit: 101539000.00
CRCT cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 10659000.00
CRCT income_statement (quarterly, 2025-06-30) — Interest Expense: 81000.00
CRCT income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 81000.00
CRCT income_statement (quarterly, 2025-06-30) — Interest Income: 3578000.00
CRCT income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 3578000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Inventory: 124796000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Invested Capital: 308937000.00
CRCT cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 20412000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 9784000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 9784000.00
CRCT cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -4741000.00
CRCT cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -361000.00
CRCT income_statement (quarterly, 2025-06-30) — Net Income: 24488000.00
CRCT income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 24488000.00
CRCT income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 24488000.00
CRCT income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 24488000.00
CRCT income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 24488000.00
CRCT cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 24488000.00
CRCT income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 24488000.00
CRCT income_statement (quarterly, 2025-06-30) — Net Interest Income: 3497000.00
CRCT cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 26114000.00
CRCT income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 3497000.00
CRCT cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -6391000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Net PPE: 50217000.00
CRCT cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -5702000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 308937000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 49560000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 2585000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 2585000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 49560000.00
CRCT income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 39902000.00
CRCT income_statement (quarterly, 2025-06-30) — Normalized Income: 24488000.00
CRCT cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 36157000.00
CRCT cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -361000.00
CRCT income_statement (quarterly, 2025-06-30) — Operating Income: 30105000.00
CRCT income_statement (quarterly, 2025-06-30) — Operating Revenue: 172112000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 212466401.00
CRCT balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 15459000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 560000.00
CRCT income_statement (quarterly, 2025-06-30) — Other Gand A: 18795000.00
CRCT income_statement (quarterly, 2025-06-30) — Other Income Expense: 241000.00
CRCT cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 959000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 22548000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 7101000.00
CRCT income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 241000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Other Properties: 37736000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 78884000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Payables: 276791000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 338448000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CRCT income_statement (quarterly, 2025-06-30) — Pretax Income: 33843000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CRCT cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: -6213000.00
CRCT cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
CRCT cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -5702000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Receivables: 81990000.00
CRCT income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 70573000.00
CRCT income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 5978000.00
CRCT cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -4741000.00
CRCT income_statement (quarterly, 2025-06-30) — Research And Development: 16762000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 0.00
CRCT cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 26114000.00
CRCT income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 35877000.00
CRCT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 54672000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Share Issued: 212466401.00
CRCT cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 9688000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 308937000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 308937000.00
CRCT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CRCT income_statement (quarterly, 2025-06-30) — Tax Provision: 9355000.00
CRCT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.28
CRCT balance_sheet (quarterly, 2025-06-30) — Total Assets: 721511000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 308937000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Total Debt: 13393000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 308937000.00
CRCT income_statement (quarterly, 2025-06-30) — Total Expenses: 142007000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 412574000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 122325000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 19470000.00
CRCT income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 30105000.00
CRCT balance_sheet (quarterly, 2025-06-30) — Working Capital: 206082000.00
CRCT income_statement (quarterly, 2025-09-30) — +Operating Expense: 71445000.00
CRCT income_statement (quarterly, 2025-09-30) — +Total Revenue: 170437000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 68323000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 88540000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 337575000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -1400000.00
CRCT cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: -381000.00
CRCT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 212257907.00
CRCT income_statement (quarterly, 2025-09-30) — Basic EPS: 0.10
CRCT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 298057000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 11686000.00
CRCT cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -6589000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 12514000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 212000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 187873000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 207102000.00
CRCT cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -180581000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 26367000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Cash Financial: 161506000.00
CRCT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -182934000.00
CRCT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 52371000.00
CRCT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 20475000.00
CRCT cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -3575000.00
CRCT cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 4250000.00
CRCT cash_flow (quarterly, 2025-09-30) — Change In Inventory: -2011000.00
CRCT cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 163000.00
CRCT cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -878000.00
CRCT cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -1939000.00
CRCT cash_flow (quarterly, 2025-09-30) — Change In Payable: -3575000.00
CRCT cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 675000.00
CRCT cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 5734000.00
CRCT cash_flow (quarterly, 2025-09-30) — Change In Receivables: -6437000.00
CRCT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -4693000.00
CRCT cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -6437000.00
CRCT cash_flow (quarterly, 2025-09-30) — Changes In Cash: -110088000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Common Stock: 212000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 358392000.00
CRCT cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -2353000.00
CRCT income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 76341000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 65947000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Current Assets: 441098000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 3607000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 3607000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 49115000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 49115000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 187038000.00
CRCT cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -3846000.00
CRCT cash_flow (quarterly, 2025-09-30) — Deferred Tax: -3846000.00
CRCT cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 6053000.00
CRCT cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 6053000.00
CRCT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 215287127.00
CRCT income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.10
CRCT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 20512000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 46000.00
CRCT income_statement (quarterly, 2025-09-30) — EBIT: 25814000.00
CRCT income_statement (quarterly, 2025-09-30) — EBITDA: 31867000.00
CRCT cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -96000.00
CRCT cash_flow (quarterly, 2025-09-30) — End Cash Position: 187873000.00
CRCT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -182934000.00
CRCT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 13886000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 93000.00
CRCT income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 17113000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 89940000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Gross PPE: 50353000.00
CRCT income_statement (quarterly, 2025-09-30) — Gross Profit: 94096000.00
CRCT cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 4271000.00
CRCT income_statement (quarterly, 2025-09-30) — Interest Expense: 183000.00
CRCT income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 183000.00
CRCT income_statement (quarterly, 2025-09-30) — Interest Income: 2342000.00
CRCT income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2342000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Inventory: 134899000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 358392000.00
CRCT cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 52371000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 8907000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 8907000.00
CRCT cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -2353000.00
CRCT cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 268000.00
CRCT income_statement (quarterly, 2025-09-30) — Net Income: 20512000.00
CRCT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 20512000.00
CRCT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 20512000.00
CRCT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 20512000.00
CRCT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 20512000.00
CRCT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 20512000.00
CRCT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 20512000.00
CRCT income_statement (quarterly, 2025-09-30) — Net Interest Income: 2159000.00
CRCT cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 58960000.00
CRCT income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 2159000.00
CRCT cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
CRCT balance_sheet (quarterly, 2025-09-30) — Net PPE: 50353000.00
CRCT cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -6589000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 358392000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 53553000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 2578000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 2578000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 53553000.00
CRCT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 31867000.00
CRCT income_statement (quarterly, 2025-09-30) — Normalized Income: 20512000.00
CRCT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 20475000.00
CRCT cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 268000.00
CRCT income_statement (quarterly, 2025-09-30) — Operating Income: 22651000.00
CRCT income_statement (quarterly, 2025-09-30) — Operating Revenue: 170437000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 212194793.00
CRCT balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 10557000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 93000.00
CRCT income_statement (quarterly, 2025-09-30) — Other Gand A: 17113000.00
CRCT income_statement (quarterly, 2025-09-30) — Other Income Expense: 821000.00
CRCT cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 43000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 19250000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 7339000.00
CRCT income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 821000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Other Properties: 38667000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 19229000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Payables: 68369000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 134316000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CRCT income_statement (quarterly, 2025-09-30) — Pretax Income: 25631000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CRCT cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: -4865000.00
CRCT cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
CRCT cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -6589000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Receivables: 88540000.00
CRCT income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 76341000.00
CRCT income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 6053000.00
CRCT cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -2353000.00
CRCT income_statement (quarterly, 2025-09-30) — Research And Development: 16865000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 20512000.00
CRCT cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 58960000.00
CRCT income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 37467000.00
CRCT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 54580000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Share Issued: 212194793.00
CRCT cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 7384000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 358392000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 358392000.00
CRCT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CRCT income_statement (quarterly, 2025-09-30) — Tax Provision: 5119000.00
CRCT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.20
CRCT balance_sheet (quarterly, 2025-09-30) — Total Assets: 564254000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 358392000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Total Debt: 12514000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 358392000.00
CRCT income_statement (quarterly, 2025-09-30) — Total Expenses: 147786000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 205862000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 123156000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 18824000.00
CRCT income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 22651000.00
CRCT balance_sheet (quarterly, 2025-09-30) — Working Capital: 254060000.00
CRCT income_statement (annual, 2025-12-31) — +Operating Expense: 294398000.00
CRCT income_statement (quarterly, 2025-12-31) — +Operating Expense: 82512000.00
CRCT income_statement (annual, 2025-12-31) — +Total Revenue: 708780000.00
CRCT income_statement (quarterly, 2025-12-31) — +Total Revenue: 203597000.00
CRCT balance_sheet (annual, 2025-12-31) — Accounts Payable: 71553000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 71553000.00
CRCT balance_sheet (annual, 2025-12-31) — Accounts Receivable: 82125000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 82125000.00
CRCT balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -138479000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -138479000.00
CRCT balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 339224000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 339224000.00
CRCT cash_flow (annual, 2025-12-31) — Asset Impairment Charge: -1053000.00
CRCT cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 922000.00
CRCT income_statement (annual, 2025-12-31) — Basic Average Shares: 215183706.00
CRCT income_statement (quarterly, 2025-12-31) — Basic Average Shares: 211863362.00
CRCT income_statement (annual, 2025-12-31) — Basic EPS: 0.36
CRCT income_statement (quarterly, 2025-12-31) — Basic EPS: 0.04
CRCT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 232140000.00
CRCT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 187873000.00
CRCT balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 10880000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 10880000.00
CRCT cash_flow (annual, 2025-12-31) — Capital Expenditure: -24417000.00
CRCT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -7234000.00
CRCT balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 11624000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 11624000.00
CRCT balance_sheet (annual, 2025-12-31) — Capital Stock: 211000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 211000.00
CRCT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 256216000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 256216000.00
CRCT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 275650000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 275650000.00
CRCT cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -202103000.00
CRCT cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -29000.00
CRCT balance_sheet (annual, 2025-12-31) — Cash Equivalents: 62034000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 62034000.00
CRCT balance_sheet (annual, 2025-12-31) — Cash Financial: 194182000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Cash Financial: 194182000.00
CRCT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -237445000.00
CRCT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -6962000.00
CRCT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 60657000.00
CRCT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -7234000.00
CRCT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 200230000.00
CRCT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 82432000.00
CRCT cash_flow (annual, 2025-12-31) — Change In Account Payable: 16854000.00
CRCT cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 2094000.00
CRCT cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -8774000.00
CRCT cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 4134000.00
CRCT cash_flow (annual, 2025-12-31) — Change In Inventory: 41161000.00
CRCT cash_flow (quarterly, 2025-12-31) — Change In Inventory: 38385000.00
CRCT cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -3223000.00
CRCT cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 93000.00
CRCT cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -3968000.00
CRCT cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -893000.00
CRCT cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 5029000.00
CRCT cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 1589000.00
CRCT cash_flow (annual, 2025-12-31) — Change In Payable: 16854000.00
CRCT cash_flow (quarterly, 2025-12-31) — Change In Payable: 2094000.00
CRCT cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 8080000.00
CRCT cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 6228000.00
CRCT cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -2429000.00
CRCT cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -18925000.00
CRCT cash_flow (annual, 2025-12-31) — Change In Receivables: 12618000.00
CRCT cash_flow (quarterly, 2025-12-31) — Change In Receivables: -3391000.00
CRCT cash_flow (annual, 2025-12-31) — Change In Working Capital: 57268000.00
CRCT cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 23086000.00
CRCT cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 12618000.00
CRCT cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -3391000.00
CRCT cash_flow (annual, 2025-12-31) — Changes In Cash: 23442000.00
CRCT cash_flow (quarterly, 2025-12-31) — Changes In Cash: 68236000.00
CRCT balance_sheet (annual, 2025-12-31) — Common Stock: 211000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Common Stock: 211000.00
CRCT cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -202103000.00
CRCT balance_sheet (annual, 2025-12-31) — Common Stock Equity: 343561000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 343561000.00
CRCT cash_flow (annual, 2025-12-31) — Common Stock Payments: -24748000.00
CRCT cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -5654000.00
CRCT balance_sheet (annual, 2025-12-31) — Construction In Progress: 5270000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 5270000.00
CRCT income_statement (annual, 2025-12-31) — Cost Of Revenue: 318349000.00
CRCT income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 107149000.00
CRCT balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 71146000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 71146000.00
CRCT balance_sheet (annual, 2025-12-31) — Current Assets: 499591000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Current Assets: 499591000.00
CRCT balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 3606000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 3606000.00
CRCT balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 3606000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 3606000.00
CRCT balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 50409000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 50409000.00
CRCT balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 50409000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 50409000.00
CRCT balance_sheet (annual, 2025-12-31) — Current Liabilities: 221075000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 221075000.00
CRCT cash_flow (annual, 2025-12-31) — Deferred Income Tax: 26117000.00
CRCT cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 40337000.00
CRCT cash_flow (annual, 2025-12-31) — Deferred Tax: 26117000.00
CRCT cash_flow (quarterly, 2025-12-31) — Deferred Tax: 40337000.00
CRCT cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 24439000.00
CRCT cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 6303000.00
CRCT cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 24439000.00
CRCT cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 6303000.00
CRCT income_statement (annual, 2025-12-31) — Diluted Average Shares: 217309035.00
CRCT income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 214689891.00
CRCT income_statement (annual, 2025-12-31) — Diluted EPS: 0.35
CRCT income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.04
CRCT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 76705000.00
CRCT income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 7791000.00
CRCT balance_sheet (annual, 2025-12-31) — Dividends Payable: 24361000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 24361000.00
CRCT income_statement (annual, 2025-12-31) — EBIT: 108460000.00
CRCT income_statement (quarterly, 2025-12-31) — EBIT: 16022000.00
CRCT income_statement (annual, 2025-12-31) — EBITDA: 132899000.00
CRCT income_statement (quarterly, 2025-12-31) — EBITDA: 22325000.00
CRCT cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 634000.00
CRCT cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 107000.00
CRCT cash_flow (annual, 2025-12-31) — End Cash Position: 256216000.00
CRCT cash_flow (quarterly, 2025-12-31) — End Cash Position: 256216000.00
CRCT cash_flow (annual, 2025-12-31) — Financing Cash Flow: -237445000.00
CRCT cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -6962000.00
CRCT cash_flow (annual, 2025-12-31) — Free Cash Flow: 175813000.00
CRCT cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 75198000.00
CRCT balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 166000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 166000.00
CRCT income_statement (annual, 2025-12-31) — General And Administrative Expense: 68464000.00
CRCT income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 15891000.00
CRCT balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 82125000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 82125000.00
CRCT balance_sheet (annual, 2025-12-31) — Gross PPE: 189619000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Gross PPE: 189619000.00
CRCT income_statement (annual, 2025-12-31) — Gross Profit: 390431000.00
CRCT income_statement (quarterly, 2025-12-31) — Gross Profit: 96448000.00
CRCT cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 15349000.00
CRCT cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 140000.00
CRCT income_statement (annual, 2025-12-31) — Interest Expense: 567000.00
CRCT income_statement (quarterly, 2025-12-31) — Interest Expense: 224000.00
CRCT income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 567000.00
CRCT income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 224000.00
CRCT income_statement (annual, 2025-12-31) — Interest Income: 11389000.00
CRCT income_statement (quarterly, 2025-12-31) — Interest Income: 2112000.00
CRCT income_statement (annual, 2025-12-31) — Interest Income Non Operating: 11389000.00
CRCT income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 2112000.00
CRCT balance_sheet (annual, 2025-12-31) — Inventory: 102664000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Inventory: 102664000.00
CRCT balance_sheet (annual, 2025-12-31) — Invested Capital: 343561000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 343561000.00
CRCT cash_flow (annual, 2025-12-31) — Investing Cash Flow: 60657000.00
CRCT cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -7234000.00
CRCT balance_sheet (annual, 2025-12-31) — Leases: 5111000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Leases: 5111000.00
CRCT balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 8018000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 8018000.00
CRCT balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 8018000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 8018000.00
CRCT balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 139481000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 139481000.00
CRCT cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -24748000.00
CRCT cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -5654000.00
CRCT cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -1077000.00
CRCT cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -350000.00
CRCT income_statement (annual, 2025-12-31) — Net Income: 76705000.00
CRCT income_statement (quarterly, 2025-12-31) — Net Income: 7791000.00
CRCT income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 76705000.00
CRCT income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 7791000.00
CRCT income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 76705000.00
CRCT income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 7791000.00
CRCT income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 76705000.00
CRCT income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 7791000.00
CRCT income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 76705000.00
CRCT income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 7791000.00
CRCT cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 76705000.00
CRCT cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 7791000.00
CRCT income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 76705000.00
CRCT income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 7791000.00
CRCT income_statement (annual, 2025-12-31) — Net Interest Income: 10822000.00
CRCT income_statement (quarterly, 2025-12-31) — Net Interest Income: 1888000.00
CRCT cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 85074000.00
CRCT cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
CRCT income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 10822000.00
CRCT income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 1888000.00
CRCT cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -10594000.00
CRCT cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1279000.00
CRCT balance_sheet (annual, 2025-12-31) — Net PPE: 51140000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Net PPE: 51140000.00
CRCT cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -24417000.00
CRCT cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -7234000.00
CRCT balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 343561000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 343561000.00
CRCT balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 13210000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 13210000.00
CRCT balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 2872000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 2872000.00
CRCT balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 2872000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 2872000.00
CRCT balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 13210000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 13210000.00
CRCT income_statement (annual, 2025-12-31) — Normalized EBITDA: 132899000.00
CRCT income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 22325000.00
CRCT income_statement (annual, 2025-12-31) — Normalized Income: 76705000.00
CRCT income_statement (quarterly, 2025-12-31) — Normalized Income: 7791000.00
CRCT cash_flow (annual, 2025-12-31) — Operating Cash Flow: 200230000.00
CRCT cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 82432000.00